IRIS
SAITTA, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.707
EU - Europa 6.554
AS - Asia 2.961
SA - Sud America 862
Continente sconosciuto - Info sul continente non disponibili 274
AF - Africa 124
OC - Oceania 14
Totale 17.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.492
RU - Federazione Russa 3.393
SG - Singapore 1.156
CN - Cina 902
BR - Brasile 733
IE - Irlanda 691
IT - Italia 646
SE - Svezia 555
HK - Hong Kong 296
DE - Germania 274
PL - Polonia 237
VN - Vietnam 181
FR - Francia 170
FI - Finlandia 146
GB - Regno Unito 142
IN - India 106
UA - Ucraina 102
CA - Canada 80
BD - Bangladesh 66
AR - Argentina 46
MX - Messico 40
BE - Belgio 37
NL - Olanda 35
ZA - Sudafrica 31
AT - Austria 28
ID - Indonesia 28
TR - Turchia 28
PK - Pakistan 23
CI - Costa d'Avorio 22
JP - Giappone 21
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
IQ - Iraq 19
EC - Ecuador 18
ES - Italia 18
JM - Giamaica 18
MA - Marocco 18
CO - Colombia 17
IL - Israele 15
AE - Emirati Arabi Uniti 14
CR - Costa Rica 14
EE - Estonia 13
SV - El Salvador 13
VE - Venezuela 12
JO - Giordania 11
PH - Filippine 11
SA - Arabia Saudita 11
HN - Honduras 10
PY - Paraguay 10
KE - Kenya 9
MY - Malesia 9
CH - Svizzera 8
EG - Egitto 8
GT - Guatemala 8
PR - Porto Rico 8
CL - Cile 7
DZ - Algeria 7
NZ - Nuova Zelanda 7
SC - Seychelles 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
BO - Bolivia 6
NP - Nepal 6
TT - Trinidad e Tobago 6
AL - Albania 5
KG - Kirghizistan 5
OM - Oman 5
BG - Bulgaria 4
BY - Bielorussia 4
CW - ???statistics.table.value.countryCode.CW??? 4
GH - Ghana 4
LB - Libano 4
LV - Lettonia 4
NI - Nicaragua 4
PE - Perù 4
AZ - Azerbaigian 3
DK - Danimarca 3
GE - Georgia 3
GP - Guadalupe 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LT - Lituania 2
LY - Libia 2
NO - Norvegia 2
SN - Senegal 2
AM - Armenia 1
BH - Bahrain 1
BS - Bahamas 1
ET - Etiopia 1
Totale 17.205
Salva come PNG Salva come JPEG
Città #
Ashburn 1.141
Moscow 973
Dallas 725
Singapore 692
Dublin 691
Chandler 502
San Jose 430
Nyköping 329
Hong Kong 295
Beijing 267
Messina 256
Jacksonville 230
Warsaw 230
Council Bluffs 188
The Dalles 158
Los Angeles 137
Ann Arbor 120
Dearborn 107
Lauterbourg 89
Munich 87
New York 86
Princeton 83
Medford 78
São Paulo 70
Cambridge 62
Des Moines 60
Santa Clara 60
Houston 58
Boardman 57
Ho Chi Minh City 54
Buffalo 46
Helsinki 43
Orem 43
Phoenix 43
Tianjin 43
Turku 41
Bremen 38
Brussels 37
Frankfurt am Main 36
Jinan 34
Guangzhou 32
Hanoi 32
Brooklyn 30
Redondo Beach 30
Rome 29
Brasília 28
Shenyang 27
Atlanta 26
Hyderabad 25
Pune 25
Chennai 23
Wilmington 23
Abidjan 22
Nuremberg 22
Rio de Janeiro 22
Belo Horizonte 21
Montreal 21
Nanjing 21
North Bergen 21
Catania 20
Lancaster 19
Tokyo 19
Boston 18
Columbus 18
Dong Ket 18
London 18
San Mateo 18
Shenzhen 18
Woodbridge 18
Amsterdam 17
Shanghai 17
Chicago 16
Denver 16
Jakarta 16
Haikou 15
Johannesburg 15
Vienna 15
Seattle 14
Tashkent 14
Avola 13
Curitiba 13
Mexico City 13
Palermo 13
Zhengzhou 13
Düsseldorf 12
Haiphong 12
Hangzhou 12
Hebei 12
Lawrenceville 12
Porto Alegre 12
San Salvador 12
Lahore 11
Milan 11
Newark 11
San José 11
Stockholm 11
Amman 10
Campinas 10
Charlotte 10
Kingston 10
Totale 9.782
Salva come PNG Salva come JPEG
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 285
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 283
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 279
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 278
Atrial fibrillation in patients with cirrhosis 275
Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment 270
Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. 256
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 252
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 238
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 236
Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients 231
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 231
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 227
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 226
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 226
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 225
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1 224
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 222
A 1-year study on hydroxy-methylglutaryl coenzymea reductase gene expression and polymorphisms in hypercholesterolemic treated with statins. 222
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 222
Erectile dysfunction in compensated liver cirrhosis 221
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 216
ANTIOXIDANT CAPACITY OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS (EPCS) AND CIGARETTE SMOKING 211
C-Reactive Protein (CRP) plasma levels, monocyte MCP-1 (Monocyte Chemoattractant Protein-1) and TF (Tissue Factor) mRNA in patients with primary arterial hypertension 209
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 209
Ateromasia carotidea e livelli lipidici in soggetti affetti da DM2: risultati di una analisi retrospettiva 208
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 208
Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians 205
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 205
Pulse wave velocity and augmentation index, but notintima-media thickness, are early indicators ofvascular damage in hypercholesterolemic children 200
Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number 192
Mitochondrial DNA is a target of HBV integration 192
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness 191
Biglycan expression is increased in hypertensive subjects with normal or increased carotid intima-media wall thickness 191
Circulating progenitor cells and the elderly: a seven-year observational study. 191
Anatomic variations: a rare variant of formation of the portal vein 188
Extracellular superoxide dismutase (EC-SOD) gene mutations screening in a sample of Mediterranean population 185
Circulating progenitor cells in rheumatoid arthritis: association with inflammation and oxidative stress. 184
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 183
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 181
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 177
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 175
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 172
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 172
Capacità antiossidante delle cellule progenitrici endoteliali ed abitudine al fumo di sigaretta 171
879 CHOLANGIOPATHY AND HCC IN MDR3 DEFICIENCY 169
Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. 169
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 168
Monofocal hepatocellular carcinoma: How much does size matter? 166
Olmesartan and atorvastatin are effective in improving circulating progenitor cells profile in hypertensive subjects 165
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 163
Obesity and liver cancer 162
Potenziali indicatori di longevità in una popolazione di anziani siciliani 159
Pattern of macrovascular invasion in hepatocellular carcinoma 157
Circulating progenitor cells and high density lipoprotein levels in elderly 156
Proposal of model for personalized early adapted cancer screening in people living with HIV: experience of "Gaetano Martino" Hospital University of Messina 154
The changing scenario of hepatocellular carcinoma in Italy: an update 152
Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 152
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 147
XXI National Congress of the Italian Society for the Study of Arteriosclerosis (SISA) 21–24 November, Perugia, Italy 147
CIRCULATING PROGENITOR CELLS AND HIGH DENSITY LIPOPROTEIN LEVELS IN ELDERLY 145
Fever and rhomboid target lesion in decompensated cirrhosis 143
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 142
Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy 141
Smoke exposure and circulating progenitor cells: Evidence for modulation of antioxidant enzymes and cell count 141
Identification of extracellular superoxide dismutase, EC-SOD, mutations in a Sicilian population 140
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients 139
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography. 135
Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians. 134
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 131
Arterial hypertension as a comorbidity of cirrhosis 128
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 127
Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. 126
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 121
Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR. 120
Oxidative stress and flogosis: The role of endothelial progenitor cells in rheumathoid arthtritis 119
Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in hypercholesterolemic Sicilian individuals 118
PAF-AH gene polymorphisms and carotid atherosclerosis in sicilian hypercholesterolemic subjects 117
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 116
Vit d deficiency, depletion of circulating endothelial progenitor cells and impaired arterial stiffness in patients with ra 116
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 115
Occult hepatitis B virus infection: an update 114
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 110
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 105
Virological profiles in hepatitis B virus / hepatitis C virus co-infected patients under interferon plus ribavirin therapy. 104
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus hepatitis C virus-coinfected patients 103
Toll-like receptor 3 and interleukine 1b expression in circulating progenitor cells isolated from patients with rheumatoid arthritis 102
The paraoxonase promoter polymorphism (-107)T > C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients 100
Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. 98
Treatment of the Hepatitis B Virus and Hepatitis C Virus Combined Infection: Still a Challenge for the Hepatologist. 97
Occult hepatitis B virus and hepatocellular carcinoma. 96
The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2 96
Tissue Factor and Monocyte Chemoattractant Protein-1 expression in hypertensive subjects with normal or increased carotid intima-media thickness 93
Hepatocellular carcinoma: the point of view of the hepatitis B virus. 93
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 90
Atezolizumab plus Bevacizumab after first-line multikinase inhibitors for advanced hepatocellular carcinoma: The concept of “drug class change” 90
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 89
OCCULT HBV IS HIGHLY PREVALENT IN PATIENTS WITH INTRAHEPATIC CHOLANGIOCARCINOMA AND IT IS DETECTED AS BOTH FREE EPISOMAL AND INTEGRATED DNA 88
Absence of Viral Replication Is Associated With Improved Outcome in Anti‐HCV‐Positive Patients With Hepatocellular Carcinoma 84
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world 83
Totale 16.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022506 0 0 0 0 27 15 37 23 9 127 87 181
2022/20231.924 140 206 76 154 162 174 24 126 803 10 36 13
2023/2024484 37 79 27 40 32 109 3 22 2 49 21 63
2024/20252.519 30 70 75 154 162 128 95 452 584 159 245 365
2025/20268.325 423 623 619 493 643 1.658 947 1.066 1.091 407 186 169
2026/20271.774 240 562 400 505 67 0 0 0 0 0 0 0
Totale 17.496